Bruck Kifle

Array ( [id] => 7688810 [patent_doc_number] => 20070105888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => '41-Methoxy isotope labeled rapamycin 42-ester' [patent_app_type] => utility [patent_app_number] => 11/592518 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7352 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105888.pdf [firstpage_image] =>[orig_patent_app_number] => 11592518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688849 [patent_doc_number] => 20070105849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Rifamycin analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/591971 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17997 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105849.pdf [firstpage_image] =>[orig_patent_app_number] => 11591971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035336 [patent_doc_number] => 20070099875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Aspartyl protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/589387 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11882 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099875.pdf [firstpage_image] =>[orig_patent_app_number] => 11589387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035359 [patent_doc_number] => 20070099898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Heterocyclic aspartyl protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/586151 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11954 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099898.pdf [firstpage_image] =>[orig_patent_app_number] => 11586151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7601769 [patent_doc_number] => 07384932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'δd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 11/545362 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1426 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384932.pdf [firstpage_image] =>[orig_patent_app_number] => 11545362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876408 [patent_doc_number] => 07358240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'δ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 11/544910 [patent_app_country] => US [patent_app_date] => 2006-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1409 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358240.pdf [firstpage_image] =>[orig_patent_app_number] => 11544910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337949 [patent_doc_number] => 20090054413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Novel 5,6-Dihydropyrazolo[3,4-E] [L,4]Diazepin-4 (IH) -One Derivatives for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease' [patent_app_type] => utility [patent_app_number] => 12/088552 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19432 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054413.pdf [firstpage_image] =>[orig_patent_app_number] => 12088552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000578 [patent_doc_number] => 20070043212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'CROWN ETHER DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/538010 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 31065 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043212.pdf [firstpage_image] =>[orig_patent_app_number] => 11538010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5136483 [patent_doc_number] => 20070078112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals' [patent_app_type] => utility [patent_app_number] => 11/527581 [patent_app_country] => US [patent_app_date] => 2006-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19794 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078112.pdf [firstpage_image] =>[orig_patent_app_number] => 11527581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840401 [patent_doc_number] => 20080280887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Selected Cgrp-Antagonists, Processes for Preparing Them and Their Use as Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 12/067885 [patent_app_country] => US [patent_app_date] => 2006-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14424 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280887.pdf [firstpage_image] =>[orig_patent_app_number] => 12067885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172414 [patent_doc_number] => 20070072847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/533096 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31880 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072847.pdf [firstpage_image] =>[orig_patent_app_number] => 11533096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205650 [patent_doc_number] => 20070027132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Hydroxyalkanoylaminolactams and related structures as inhibitors of Alphabeta protein production' [patent_app_type] => utility [patent_app_number] => 11/522699 [patent_app_country] => US [patent_app_date] => 2006-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46820 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027132.pdf [firstpage_image] =>[orig_patent_app_number] => 11522699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7599694 [patent_doc_number] => 07582753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Process for the preparation of benzotriazepine derivatives' [patent_app_type] => utility [patent_app_number] => 11/531794 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12197 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582753.pdf [firstpage_image] =>[orig_patent_app_number] => 11531794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205651 [patent_doc_number] => 20070027133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'BICYCLIC PYRAZOLYL AND IMIDAZOLYL COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/470695 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31142 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027133.pdf [firstpage_image] =>[orig_patent_app_number] => 11470695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368810 [patent_doc_number] => 20090306369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'PROCESS FOR PREPARING BENZAZEPINE COMPOUNDS OR SALTS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/064178 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12430 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306369.pdf [firstpage_image] =>[orig_patent_app_number] => 12064178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446964 [patent_doc_number] => 20100279995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Novel Ansamycin Derivatives' [patent_app_type] => utility [patent_app_number] => 12/063791 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19761 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279995.pdf [firstpage_image] =>[orig_patent_app_number] => 12063791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 460046 [patent_doc_number] => 07241755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => 'Epothilone derivatives' [patent_app_type] => utility [patent_app_number] => 11/512623 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15232 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241755.pdf [firstpage_image] =>[orig_patent_app_number] => 11512623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225600 [patent_doc_number] => 20070254867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Heterocyclic Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/466638 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 275071 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254867.pdf [firstpage_image] =>[orig_patent_app_number] => 11466638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183541 [patent_doc_number] => 20070054895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => '2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents' [patent_app_type] => utility [patent_app_number] => 11/508547 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34328 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054895.pdf [firstpage_image] =>[orig_patent_app_number] => 11508547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149548 [patent_doc_number] => 20070049608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use' [patent_app_type] => utility [patent_app_number] => 11/508116 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17111 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049608.pdf [firstpage_image] =>[orig_patent_app_number] => 11508116 [rel_patent_id] =>[rel_patent_doc_number] =>)